TABITHA TRAPASSO: Open Payments
NPI 1952835795 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$523 in 13 payments from 3 companies in 2025. Trend: 2023 $887 · 2024 $614 · 2025 $523
Food & beverage: $523
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $282 |
| Otsuka America Pharmaceutical, Inc. | 3 | $162 |
| Neurocrine BioSciences, Inc. | 3 | $80 |
Products named: CAPLYTA, REXULTI, INGREZZA, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
